Literature DB >> 29573988

Structural Insights into the Induced-fit Inhibition of Fascin by a Small-Molecule Inhibitor.

Jianyun Huang1, Raja Dey1, Yufeng Wang1, Jean Jakoncic2, Igor Kurinov3, Xin-Yun Huang4.   

Abstract

Tumor metastasis is responsible for ~90% of all cancer deaths. One of the key steps of tumor metastasis is tumor cell migration and invasion. Filopodia are cell surface extensions that are critical for tumor cell migration. Fascin protein is the main actin-bundling protein in filopodia. Small-molecule fascin inhibitors block tumor cell migration, invasion, and metastasis. Here we present the structural basis for the mechanism of action of these small-molecule fascin inhibitors. X-ray crystal structural analysis of a complex of fascin and a fascin inhibitor shows that binding of the fascin inhibitor to the hydrophobic cleft between the domains 1 and 2 of fascin induces a ~35o rotation of domain 1, leading to the distortion of both the actin-binding sites 1 and 2 on fascin. Furthermore, the crystal structures of an inhibitor alone indicate that the conformations of the small-molecule inhibitors are dynamic. Mutations of the inhibitor-interacting residues decrease the sensitivity of fascin to the inhibitors. Our studies provide structural insights into the molecular mechanism of fascin protein function as well as the action of small-molecule fascin inhibitors.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  actin cytoskeleton; crystal structure; fascin; small-molecule inhibitor

Mesh:

Substances:

Year:  2018        PMID: 29573988      PMCID: PMC5916032          DOI: 10.1016/j.jmb.2018.03.009

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  49 in total

1.  Molecular mechanism of fascin function in filopodial formation.

Authors:  Shengyu Yang; Fang-Ke Huang; Jianyun Huang; Shuai Chen; Jean Jakoncic; Alejandra Leo-Macias; Ruben Diaz-Avalos; Lin Chen; J Jillian Zhang; Xin-Yun Huang
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

2.  Filopodia formation by crosslinking of F-actin with fascin in two different binding manners.

Authors:  Shinji Aramaki; Kouta Mayanagi; Mingyue Jin; Kazuhiro Aoyama; Takuo Yasunaga
Journal:  Cytoskeleton (Hoboken)       Date:  2016-06-13

Review 3.  Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker?

Authors:  Yosuke Hashimoto; Marek Skacel; Josephine C Adams
Journal:  Int J Biochem Cell Biol       Date:  2005-09       Impact factor: 5.085

4.  Formation of filopodia in coelomocytes: localization of fascin, a 58,000 dalton actin cross-linking protein.

Authors:  J J Otto; R E Kane; J Bryan
Journal:  Cell       Date:  1979-06       Impact factor: 41.582

Review 5.  The great escape: when cancer cells hijack the genes for chemotaxis and motility.

Authors:  John Condeelis; Robert H Singer; Jeffrey E Segall
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

6.  Purification and characterization of an F-actin-bundling 55-kilodalton protein from HeLa cells.

Authors:  S Yamashiro-Matsumura; F Matsumura
Journal:  J Biol Chem       Date:  1985-04-25       Impact factor: 5.157

7.  Separation and interaction of the major components of sea urchin actin gel.

Authors:  J Bryan; R E Kane
Journal:  J Mol Biol       Date:  1978-10-25       Impact factor: 5.469

8.  Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer.

Authors:  A Grothey; R Hashizume; A A Sahin; P D McCrea
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

Review 9.  Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis.

Authors:  Vanessa Y Tan; Sarah J Lewis; Josephine C Adams; Richard M Martin
Journal:  BMC Med       Date:  2013-02-26       Impact factor: 8.775

10.  Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes.

Authors:  Ang Li; Jennifer P Morton; YaFeng Ma; Saadia A Karim; Yan Zhou; William J Faller; Emma F Woodham; Hayley T Morris; Richard P Stevenson; Amelie Juin; Nigel B Jamieson; Colin J MacKay; C Ross Carter; Hing Y Leung; Shigeko Yamashiro; Karen Blyth; Owen J Sansom; Laura M Machesky
Journal:  Gastroenterology       Date:  2014-01-23       Impact factor: 22.682

View more
  10 in total

1.  Novel anti-invasive properties of a Fascin1 inhibitor on colorectal cancer cells.

Authors:  Silvia Montoro-García; Begoña Alburquerque-González; Ángel Bernabé-García; Manuel Bernabé-García; Priscila Campioni Rodrigues; Helena den-Haan; Irene Luque; Francisco José Nicolás; Horacio Pérez-Sánchez; María Luisa Cayuela; Tuula Salo; Pablo Conesa-Zamora
Journal:  J Mol Med (Berl)       Date:  2020-01-29       Impact factor: 4.599

2.  Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.

Authors:  Sean McGuire; Betul Kara; Peter C Hart; Anthony Montag; Kristen Wroblewski; Sarah Fazal; Xin-Yun Huang; Ernst Lengyel; Hilary A Kenny
Journal:  Gynecol Oncol       Date:  2019-02-20       Impact factor: 5.482

Review 3.  The post-translational modification of Fascin: impact on cell biology and its associations with inhibiting tumor metastasis.

Authors:  Zhi-Da Zhang; Rong-Rong Li; Jia-You Chen; Hong-Xin Huang; Yin-Wei Cheng; Li-Yan Xu; En-Min Li
Journal:  Amino Acids       Date:  2022-08-08       Impact factor: 3.789

Review 4.  Role of actin cytoskeleton in podocytes.

Authors:  Sanja Sever
Journal:  Pediatr Nephrol       Date:  2020-11-13       Impact factor: 3.651

5.  Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents.

Authors:  Stuart Francis; Daniel Croft; Alexander W Schüttelkopf; Charles Parry; Angelo Pugliese; Ken Cameron; Sophie Claydon; Martin Drysdale; Claire Gardner; Andrea Gohlke; Gillian Goodwin; Christopher H Gray; Jennifer Konczal; Laura McDonald; Mokdad Mezna; Andrew Pannifer; Nikki R Paul; Laura Machesky; Heather McKinnon; Justin Bower
Journal:  Bioorg Med Chem Lett       Date:  2019-01-30       Impact factor: 2.823

6.  Knockdown of Ski decreases osteosarcoma cell proliferation and migration by suppressing the PI3K/Akt signaling pathway.

Authors:  Xin Zhao; Yuying Fang; Xingwen Wang; Zhouyuan Yang; Donghai Li; Meng Tian; Pengde Kang
Journal:  Int J Oncol       Date:  2019-11-14       Impact factor: 5.650

7.  Fascin inhibitor increases intratumoral dendritic cell activation and anti-cancer immunity.

Authors:  Yufeng Wang; Mei Song; Ming Liu; Guoan Zhang; Xian Zhang; Ming O Li; Xiaojing Ma; J Jillian Zhang; Xin-Yun Huang
Journal:  Cell Rep       Date:  2021-04-06       Impact factor: 9.423

8.  Redox Potentials of Disulfide Bonds in LOXL2 Studied by Nonequilibrium Alchemical Simulation.

Authors:  Lirui Lin; Haiying Zou; Wenjin Li; Li-Yan Xu; En-Min Li; Geng Dong
Journal:  Front Chem       Date:  2021-12-14       Impact factor: 5.221

9.  Fascin Inhibitors Decrease Cell Migration and Adhesion While Increase Overall Survival of Mice Bearing Bladder Cancers.

Authors:  Zhankui Zhao; Yufeng Wang; J Jillian Zhang; Xin-Yun Huang
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

10.  An optogenetic model reveals cell shape regulation through FAK and fascin.

Authors:  Jean A Castillo-Badillo; N Gautam
Journal:  J Cell Sci       Date:  2021-07-08       Impact factor: 5.235

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.